SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on August 22, 2002; DOI 10.1182/blood-2002-05-1496. This Article Full Text Full Text (PDF) All Versions of this Article: 2002-05-1496v1 100/13/4358    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Marr, K. A. Articles by Corey, L. Search for Related Content PubMed PubMed Citation Articles by Marr, K. A. Articles by Corey, L. Related Collections Transplantation Clinical Trials and Observations Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 15 December 2002, Vol. 100, No. 13, pp. 4358-4366 CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Kieren A. Marr, Rachel A. Carter, Michael Boeckh, Paul Martin, and Lawrence Corey From the Fred Hutchinson Cancer Research Center Programs in Infectious Diseases and Long-term Follow-up, Seattle, WA, and the University of Washington Department of Medicine and Laboratory Medicine, Seattle. The incidence of postengraftment invasive aspergillosis (IA) in hematopoietic stem cell transplant (HSCT) recipients increased during the 1990s. We determined risks for IA and outcomes among 1682 patients who received HSCTs between January 1993 and December 1998. Risk factors included host variables (age, underlying disease), transplant variables (stem cell source), and late complications (acute and chronic graft-versus-host disease [GVHD], receipt of corticosteroids, secondary neutropenia, cytomegalovirus [CMV] disease, and respiratory virus infection). We identified risk factors associated with IA early after transplantation ( 40 days) and after engraftment (41-180 days). Older patient age was associated with an increased risk during both periods. Chronic myelogenous leukemia (CML) in chronic phase was associated with low risk for early IA compared with other hematologic malignancies, aplastic anemia, and myelodysplastic syndrome. Multiple myeloma was associated with an increased risk for postengraftment IA. Use of human leukocyte antigen (HLA)-matched related (MR) peripheral blood stem cells conferred protection against early IA compared with use of MR bone marrow, but use of cord blood increased the risk of IA early after transplantation. Factors that increased risks for IA after engraftment included receipt of T cell-depleted or CD34-selected stem cell products, receipt of corticosteroids, neutropenia, lymphopenia, GVHD, CMV disease, and respiratory virus infections. Very late IA (> 6 months after transplantation) was associated with chronic GVHD and CMV disease. These results emphasize the postengraftment timing of IA; risk factor analyses verify previously recognized risk factors (GVHD, receipt of corticosteroids, and neutropenia) and uncover the roles of lymphopenia and viral infections in increasing the incidence of postengraftment IA in the 1990s. © 2002 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: M. A. Pfaller, D. J. Diekema, M. A. Ghannoum, J. H. Rex, B. D. Alexander, D. Andes, S. D. Brown, V. Chaturvedi, A. Espinel-Ingroff, C. L. Fowler, et al. Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods J. Clin. Microbiol., October 1, 2009; 47(10): 3142 - 3146. [Abstract] [Full Text] [PDF] G. Maschmeyer, S. Neuburger, L. Fritz, A. Bohme, O. Penack, R. Schwerdtfeger, D. Buchheidt, W.-D. Ludwig, and on behalf of the Infectious Diseases Working Party A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients Ann. Onc., September 1, 2009; 20(9): 1560 - 1564. [Abstract] [Full Text] [PDF] R. D. Portugal, M. Garnica, and M. Nucci Index to Predict Invasive Mold Infection in High-Risk Neutropenic Patients Based on the Area Over the Neutrophil Curve J. Clin. Oncol., August 10, 2009; 27(23): 3849 - 3854. [Abstract] [Full Text] [PDF] M. Michallet and J. I. Ito Approaches to the Management of Invasive Fungal Infections in Hematologic Malignancy and Hematopoietic Cell Transplantation J. Clin. Oncol., July 10, 2009; 27(20): 3398 - 3409. [Abstract] [Full Text] [PDF] T. R. T. Dagenais and N. P. Keller Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis Clin. Microbiol. Rev., July 1, 2009; 22(3): 447 - 465. [Abstract] [Full Text] [PDF] M. L. Herrera, A. C. Vallor, J. A. Gelfond, T. F. Patterson, and B. L. Wickes Strain-Dependent Variation in 18S Ribosomal DNA Copy Numbers in Aspergillus fumigatus J. Clin. Microbiol., May 1, 2009; 47(5): 1325 - 1332. [Abstract] [Full Text] [PDF] B. H. Segal Aspergillosis N. Engl. J. Med., April 30, 2009; 360(18): 1870 - 1884. [Full Text] [PDF] L. Y. Chiang, D. C. Sheppard, F. N. Gravelat, T. F. Patterson, and S. G. Filler Aspergillus fumigatus Stimulates Leukocyte Adhesion Molecules and Cytokine Production by Endothelial Cells In Vitro and during Invasive Pulmonary Disease Infect. Immun., August 1, 2008; 76(8): 3429 - 3438. [Abstract] [Full Text] [PDF] A. Francesconi, M. Kasai, S. M. Harrington, M. G. Beveridge, R. Petraitiene, V. Petraitis, R. L. Schaufele, and T. J. Walsh Automated and Manual Methods of DNA Extraction for Aspergillus fumigatus and Rhizopus oryzae Analyzed by Quantitative Real-Time PCR J. Clin. Microbiol., June 1, 2008; 46(6): 1978 - 1984. [Abstract] [Full Text] [PDF] A. Burgos, T. E. Zaoutis, C. C. Dvorak, J. A. Hoffman, K. M. Knapp, J. J. Nania, P. Prasad, and W. J. Steinbach Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases Pediatrics, May 1, 2008; 121(5): e1286 - e1294. [Abstract] [Full Text] [PDF] J. Guinea, T. Pelaez, S. Recio, M. Torres-Narbona, and E. Bouza In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1396 - 1400. [Abstract] [Full Text] [PDF] M. A. S. H. Mennink-Kersten, D. Ruegebrink, R. R. Klont, A. Warris, N. M. A. Blijlevens, J. P. Donnelly, and P. E. Verweij Improved Detection of Circulating Aspergillus Antigen by Use of a Modified Pretreatment Procedure J. Clin. Microbiol., April 1, 2008; 46(4): 1391 - 1397. [Abstract] [Full Text] [PDF] D. A. Mitchell, W. Xie, R. Schmittling, C. Learn, A. Friedman, R. E. McLendon, and J. H. Sampson Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma Neuro-oncol, February 1, 2008; 10(1): 10 - 18. [Abstract] [Full Text] [PDF] M. Mezger, M. Steffens, M. Beyer, C. Manger, J. Eberle, M.-R. Toliat, T. F. Wienker, P. Ljungman, H. Hebart, H. J. Dornbusch, et al. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 epression in monocyte-derived dendritic cells Blood, January 15, 2008; 111(2): 534 - 536. [Abstract] [Full Text] [PDF] E. Orciuolo, M. Stanzani, M. Canestraro, S. Galimberti, G. Carulli, R. Lewis, M. Petrini, and K. V. Komanduri Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis J. Leukoc. Biol., October 1, 2007; 82(4): 839 - 848. [Abstract] [Full Text] [PDF] B. H. Segal Role of Macrophages in Host Defense Against Aspergillosis and Strategies for Immune Augmentation Oncologist, October 1, 2007; 12(suppl_2): 7 - 13. [Abstract] [Full Text] [PDF] O.S. Zmeili and A.O. Soubani Pulmonary aspergillosis: a clinical update QJM, June 1, 2007; 100(6): 317 - 334. [Abstract] [Full Text] [PDF] D. M. Hockenbery, S. Cruickshank, T. C. Rodell, T. Gooley, F. Schuening, S. Rowley, D. David, M. Brunvand, B. Berryman, S. Abhyankar, et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease Blood, May 15, 2007; 109(10): 4557 - 4563. [Abstract] [Full Text] [PDF] M. Simitsopoulou, E. Roilides, C. Likartsis, J. Ioannidis, A. Orfanou, F. Paliogianni, and T. J. Walsh Expression of Immunomodulatory Genes in Human Monocytes Induced by Voriconazole in the Presence of Aspergillus fumigatus Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1048 - 1054. [Abstract] [Full Text] [PDF] A. J. Ullmann, J. H. Lipton, D. H. Vesole, P. Chandrasekar, A. Langston, S. R. Tarantolo, H. Greinix, W. Morais de Azevedo, V. Reddy, N. Boparai, et al. Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease N. Engl. J. Med., January 25, 2007; 356(4): 335 - 347. [Abstract] [Full Text] [PDF] J. Tao, B. H. Segal, C. Eppolito, Q. Li, C. G. Dennis, R. Youn, and P. A. Shrikant Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity J. Leukoc. Biol., September 1, 2006; 80(3): 529 - 537. [Abstract] [Full Text] [PDF] H. Brodoefel, M. Vogel, H. Hebart, H. Einsele, R. Vonthein, C. Claussen, and M. Horger Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. Am. J. Roentgenol., August 1, 2006; 187(2): 404 - 413. [Abstract] [Full Text] [PDF] P. Tattevin, Y. Le Tulzo, S. Schwartz, M. Ruhnke, P. Ribaud, L. Corey, T. Driscoll, O. A. Cornely, U. Schuler, I. Lutsar, et al. Improved outcome in central nervous system aspergillosis Blood, April 15, 2006; 107(8): 3410 - 3412. [Full Text] [PDF] B. H. Segal and T. J. Walsh Current Approaches to Diagnosis and Treatment of Invasive Aspergillosis Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 707 - 717. [Abstract] [Full Text] [PDF] O. Beck, M. S. Topp, U. Koehl, E. Roilides, M. Simitsopoulou, M. Hanisch, J. Sarfati, J. P. Latge, T. Klingebiel, H. Einsele, et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus Blood, March 15, 2006; 107(6): 2562 - 2569. [Abstract] [Full Text] [PDF] K. Perruccio, A. Tosti, E. Burchielli, F. Topini, L. Ruggeri, A. Carotti, M. Capanni, E. Urbani, A. Mancusi, F. Aversa, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation Blood, December 15, 2005; 106(13): 4397 - 4406. [Abstract] [Full Text] [PDF] D. C. Sheppard, T. Doedt, L. Y. Chiang, H. S. Kim, D. Chen, W. C. Nierman, and S. G. Filler The Aspergillus fumigatus StuA Protein Governs the Up-Regulation of a Discrete Transcriptional Program during the Acquisition of Developmental Competence Mol. Biol. Cell, December 1, 2005; 16(12): 5866 - 5879. [Abstract] [Full Text] [PDF] A. Upton, A. Gugel, W. Leisenring, A. Limaye, B. Alexander, R. Hayden, and K. A. Marr Reproducibility of Low Galactomannan Enzyme Immunoassay Index Values Tested in Multiple Laboratories J. Clin. Microbiol., September 1, 2005; 43(9): 4796 - 4800. [Abstract] [Full Text] [PDF] J. Pavie, C. Lacroix, D. G. Hermoso, M. Robin, C. Ferry, A. Bergeron, M. Feuilhade, F. Dromer, E. Gluckman, J.-M. Molina, et al. Breakthrough Disseminated Aspergillus ustus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole or Caspofungin Prophylaxis J. Clin. Microbiol., September 1, 2005; 43(9): 4902 - 4904. [Abstract] [Full Text] [PDF] F. E.-H. Lee, C. C. Daigle, M. A. Urban, L. A. Metlay, J. J. Treanor, and D. R. Trawick Fever and Progressive Respiratory Failure in Three Elderly Family Members Chest, September 1, 2005; 128(3): 1863 - 1867. [Full Text] [PDF] J. W. Bok, S. A. Balajee, K. A. Marr, D. Andes, K. F. Nielsen, J. C. Frisvad, and N. P. Keller LaeA, a Regulator of Morphogenetic Fungal Virulence Factors Eukaryot. Cell, September 1, 2005; 4(9): 1574 - 1582. [Abstract] [Full Text] [PDF] W. H. Kruger, J. Bohlius, O. A. Cornely, H. Einsele, H. Hebart, G. Massenkeil, S. Schuttrumpf, G. Silling, A. J. Ullmann, D. T. Waldschmidt, et al. Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology Ann. Onc., August 1, 2005; 16(8): 1381 - 1390. [Abstract] [Full Text] [PDF] U. Hainz, P. Obexer, C. Winkler, P. Sedlmayr, O. Takikawa, H. Greinix, A. Lawitschka, U. Putschger, D. Fuchs, S. Ladisch, et al. Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation Blood, May 15, 2005; 105(10): 4127 - 4134. [Abstract] [Full Text] [PDF] M. Stanzani, E. Orciuolo, R. Lewis, D. P. Kontoyiannis, S. L. R. Martins, L. S. St. John, and K. V. Komanduri Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes Blood, March 15, 2005; 105(6): 2258 - 2265. [Abstract] [Full Text] [PDF] D. L. Coy, A. Ormazabal, J. D. Godwin, and T. Lalani Imaging Evaluation of Pulmonary and Abdominal Complications Following Hematopoietic Stem Cell Transplantation RadioGraphics, March 1, 2005; 25(2): 305 - 317. [Abstract] [Full Text] [PDF] S. Bellocchio, R. Gaziano, S. Bozza, G. Rossi, C. Montagnoli, K. Perruccio, M. Calvitti, L. Pitzurra, and L. Romani Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4 J. Antimicrob. Chemother., February 1, 2005; 55(2): 214 - 222. [Abstract] [Full Text] [PDF] N. Singh and D. L. Paterson Aspergillus Infections in Transplant Recipients Clin. Microbiol. Rev., January 1, 2005; 18(1): 44 - 69. [Abstract] [Full Text] [PDF] C. Pazos, J. Ponton, and A. D. Palacio Contribution of (1->3)-{beta}-D-Glucan Chromogenic Assay to Diagnosis and Therapeutic Monitoring of Invasive Aspergillosis in Neutropenic Adult Patients: a Comparison with Serial Screening for Circulating Galactomannan J. Clin. Microbiol., January 1, 2005; 43(1): 299 - 305. [Abstract] [Full Text] [PDF] B. Musher, D. Fredricks, W. Leisenring, S. A. Balajee, C. Smith, and K. A. Marr Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid J. Clin. Microbiol., December 1, 2004; 42(12): 5517 - 5522. [Abstract] [Full Text] [PDF] R. Gaziano, S. Bozza, S. Bellocchio, K. Perruccio, C. Montagnoli, L. Pitzurra, G. Salvatori, R. De Santis, P. Carminati, A. Mantovani, et al. Anti-Aspergillus fumigatus Efficacy of Pentraxin 3 Alone and in Combination with Antifungals Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4414 - 4421. [Abstract] [Full Text] [PDF] J.-P. Gangneux, L. Noussair, A. Bouakline, N. Roux, C. Lacroix, and F. Derouin Experimental assessment of disinfection procedures for eradication of Aspergillus fumigatus in food Blood, October 1, 2004; 104(7): 2000 - 2002. [Abstract] [Full Text] [PDF] R. M. Kotloff, V. N. Ahya, and S. W. Crawford Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 22 - 48. [Abstract] [Full Text] [PDF] L. Romani, F. Bistoni, R. Gaziano, S. Bozza, C. Montagnoli, K. Perruccio, L. Pitzurra, S. Bellocchio, A. Velardi, G. Rasi, et al. Thymosin {alpha} 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling Blood, June 1, 2004; 103(11): 4232 - 4239. [Abstract] [Full Text] [PDF] D. Montagna, F. Locatelli, A. Moretta, D. Lisini, C. Previdere, P. Grignani, P. DeStefano, G. Giorgiani, E. Montini, S. Pagani, et al. T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation Blood, June 1, 2004; 103(11): 4322 - 4329. [Abstract] [Full Text] [PDF] M. Karthaus, O. A. Cornely, and A. J. Ullmann Itraconazole versus Fluconazole for Antifungal Prophylaxis Ann Intern Med, April 6, 2004; 140(7): 579 - 580. [Full Text] [PDF] S. A. Balajee, M. Weaver, A. Imhof, J. Gribskov, and K. A. Marr Aspergillus fumigatus Variant with Decreased Susceptibility to Multiple Antifungals Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1197 - 1203. [Abstract] [Full Text] [PDF] K. A. Marr, F. Crippa, W. Leisenring, M. Hoyle, M. Boeckh, S. A. Balajee, W. G. Nichols, B. Musher, and L. Corey Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants Blood, February 15, 2004; 103(4): 1527 - 1533. [Abstract] [Full Text] [PDF] J. R. Wingard, W. G. Nichols, and G. B. McDonald Supportive Care Hematology, January 1, 2004; 2004(1): 372 - 389. [Abstract] [Full Text] [PDF] S. Bozza, K. Perruccio, C. Montagnoli, R. Gaziano, S. Bellocchio, E. Burchielli, G. Nkwanyuo, L. Pitzurra, A. Velardi, and L. Romani A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation Blood, November 15, 2003; 102(10): 3807 - 3814. [Abstract] [Full Text] [PDF] W. G. Nichols Management of Infectious Complications in the Hematopoietic Stem Cell Transplant Recipient J Intensive Care Med, November 1, 2003; 18(6): 295 - 312. [Abstract] [PDF] T. Fukuda, M. Boeckh, R. A. Carter, B. M. Sandmaier, M. B. Maris, D. G. Maloney, P. J. Martin, R. F. Storb, and K. A. Marr Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning Blood, August 1, 2003; 102(3): 827 - 833. [Abstract] [Full Text] [PDF]

	Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020